- $17.26bn
- $19.45bn
- $2.86bn
Revvity Q1 revenue rises 7%, slightly beats expectations
U.S. RESEARCH ROUNDUP-Adobe, Exxon Mobil, Stellar Bancorp
U.S. STOCKS ON THE MOVE-Abacus Global, McDonald's, Wave Life
U.S. STOCKS ON THE MOVE-Apple, ESAB, Community Bancorp
U.S. STOCKS ON THE MOVE-InMode, IDEXX, Revvity
Revvity climbs after forecasting upbeat 2026 profit on diagnostics strength
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter
Revvity's Q4 revenue, adjusted EPS rise on diagnostics growth
Brief: Revvity Inc Declares Quarterly Dividend Of $0.07 Per Share
Revvity jumps after lifting 2025 adjusted profit outlook
Brief: Revvity Inc Expect Existing End Market Trends To Continue Into 2026 - Presentation
Revvity rises as co expects to exceed 2025 profit forecast
Revvity says it will exceed 2025 profit forecast range
Health science firm Revvity's preliminary Q4 revenue beats estimates
Brief: Revvity Collaborates With Lilly To Expand Access To Ai Drug Discovery Models
U.S. STOCKS ON THE MOVE-PepGen, Turbo Energy, Qualcomm
Revvity lifts profit forecast on renewed demand in diagnostics unit (updated)
Revvity down after Q3 revenue misses estimates
U.S. STOCKS ON THE MOVE-Alphabet, Keysight Technologies, Keurig Dr Pepper